Drug intelligence / Profile preview

monacoline + berberine

Development stage
Preclinical
Lead developer
Mogon Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Monacoline + berberine (Red Rise) is a preclinical-stage oral combination small molecule drug being developed by Mogon Pharmaceuticals. It is a modified oral-release tablet formulation combining monacoline, a statin-like compound derived from red yeast rice that inhibits HMG-CoA reductase, and berberine, a plant-derived alkaloid with antidiabetic properties. The drug is primarily intended for cholesterol lowering by inhibiting the rate-limiting enzyme in cholesterol biosynthesis while providing additional metabolic benefits through its berberine component. The formulation is designed to improve the oral release profile of these active substances for enhanced therapeutic efficacy.

Brand names
Red Rise
Other names
MonacolineMevacolinBerberine
02

Targets

SREBP-1 / SREBF1 (SREBP-1)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)CYP51A1 (Sterol 14α-demethylase)AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on monacoline + berberine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on monacoline + berberine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call